A review of Ehlers-Danlos syndrome
- PMID: 32175940
- DOI: 10.1097/01.JAA.0000657160.48246.91
A review of Ehlers-Danlos syndrome
Abstract
Ehlers-Danlos syndrome (EDS) describes a group of heritable disorders of connective tissue comprising mutations in the genes involved in the structure and/or biosynthesis of collagen. Thirteen EDS subtypes are recognized, with a wide degree of symptom overlap among subtypes and with other connective tissue disorders. The clinical hallmarks of EDS are tissue fragility, joint hypermobility, and skin hyperextensibility. Appropriate diagnosis of EDS is important for correct multidisciplinary management and is associated with better clinical outcomes for patients.
References
-
- Bloom L, Byers P, Francomano C, et al. The international consortium on the Ehlers-Danlos syndromes. Am J Med Genet C Semin Med Genet. 2017;175(1):5–7.
-
- Malfait F, Francomano C, Byers P, et al. The 2017 international classification of the Ehlers-Danlos syndromes. Am J Med Genet C Semin Med Genet. 2017;175(1):8–26.
-
- Beighton P, De Paepe A, Steinmann B, et al. Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK). Am J Med Genet. 1998;77(1):31–37.
-
- Hamonet C, Schatz P-M, Bezire P, et al. Cognitive and psychopathological aspects of Ehlers-Danlos syndrome—experience in a specialized medical consultation. Res Adv Brain Disord Ther. 2018;2018(1):1–5.
-
- Castori M. Pain in Ehlers-Danlos syndromes: manifestations, therapeutic strategies and future perspectives. Expert Opin Orphan Drugs. 2016;4(11):1145–1158.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
